Terms: = Prostate cancer AND NCKIPSD, AF3P21, 51517, ENSG00000213672, SPIN90, WASLBP, Q9NZQ3, WISH, ORF1 AND Treatment
99 results:
1. SISS-MCO: large scale sparsity-induced spot selection for fast and fully-automated robust multi-criteria optimisation of proton plans.
Kong W; Oud M; Habraken SJM; Huiskes M; Astreinidou E; Rasch CRN; Heijmen BJM; Breedveld S
Phys Med Biol; 2024 Feb; 69(5):. PubMed ID: 38224619
[No Abstract] [Full Text] [Related]
2. Do all prostate cancer patients want, and experience shared decision making prior to curative treatment?
Otrebski Nilsson M; Aas K; Myklebust TÅ; Gjelsvik YM; Haug ES; Fosså SD; Johannesen TB
Scand J Urol; 2023 Dec; 58():133-140. PubMed ID: 38116675
[TBL] [Abstract] [Full Text] [Related]
3. Comparison of Hematocrit Change in Testosterone-deficient Men Treated With Intranasal Testosterone Gel vs Intramuscular Testosterone Cypionate: A Randomized Clinical Trial.
Rivero MJ; Ory J; Diaz P; Thirumavalavan N; Han S; Reis IM; Ramasamy R
J Urol; 2023 Jul; 210(1):162-170. PubMed ID: 37126399
[TBL] [Abstract] [Full Text] [Related]
4. Evaluation of Outcomes Following Focal Ablative Therapy for treatment of Localized Clinically Significant prostate cancer in Patients >70 Years: A Multi-institute, Multi-energy 15-Year Experience.
Habashy D; Reddy D; Peters M; Shah TT; van Son M; van Rossum PSN; Tanaka MB; Cullen E; Engle R; McCracken S; Greene D; Hindley RG; Emara A; Nigam R; Orczyk C; Shergill I; Persad R; Virdi J; Moore CM; Arya M; Winkler M; Emberton M; Ahmed HU; Dudderidge T
J Urol; 2023 Jul; 210(1):108-116. PubMed ID: 37014172
[TBL] [Abstract] [Full Text] [Related]
5. Vascular-targeted Photodynamic Therapy in Unilateral Low-risk prostate cancer in Germany: 2-yr Single-centre Experience in a Real-world Setting Compared with Radical prostatectomy.
Flegar L; Buerk B; Proschmann R; Propping S; Groeben C; Baunacke M; Herout R; Huber J; Thomas C; Borkowetz A
Eur Urol Focus; 2022 Jan; 8(1):121-127. PubMed ID: 33602642
[TBL] [Abstract] [Full Text] [Related]
6. Psychosocial Barriers and Enablers for prostate cancer Patients in Starting a Relationship.
Mathew S; Rapsey CM; Wibowo E
J Sex Marital Ther; 2020; 46(8):736-746. PubMed ID: 32835628
[TBL] [Abstract] [Full Text] [Related]
7. Deep learning using preoperative magnetic resonance imaging information to predict early recovery of urinary continence after robot-assisted radical prostatectomy.
Sumitomo M; Teramoto A; Toda R; Fukami N; Fukaya K; Zennami K; Ichino M; Takahara K; Kusaka M; Shiroki R
Int J Urol; 2020 Oct; 27(10):922-928. PubMed ID: 32729184
[TBL] [Abstract] [Full Text] [Related]
8. Mental distress and need for psychosocial support in prostate cancer patients: An observational cross-sectional study.
Baba N; Schrage T; Hartmann A; Baba K; Wuensch A; Schultze-Seemann W; Weis J; Joos A
Int J Psychiatry Med; 2021 Jan; 56(1):51-63. PubMed ID: 32597270
[TBL] [Abstract] [Full Text] [Related]
9. Not all prostate cancer is the same - patient perceptions: an Asia-Pacific region study.
Akakura K; Bolton D; Grillo V; Mermod N
BJU Int; 2020 Sep; 126 Suppl 1():38-45. PubMed ID: 32521568
[TBL] [Abstract] [Full Text] [Related]
10. Men's view on participation in decisions about prostate-specific antigen (PSA) screening: patient and public involvement in development of a survey.
Birkeland S; Pedersen SS; Haakonsson AK; Barry MJ; Rottmann N
BMC Med Inform Decis Mak; 2020 Apr; 20(1):65. PubMed ID: 32252729
[TBL] [Abstract] [Full Text] [Related]
11. Determinants for choosing and adhering to active surveillance for localised prostate cancer: a nationwide population-based study.
Bergengren O; Garmo H; Bratt O; Holmberg L; Johansson E; Bill-Axelson A
BMJ Open; 2019 Dec; 9(12):e033944. PubMed ID: 31874896
[TBL] [Abstract] [Full Text] [Related]
12. Assessment of Return to Baseline Urinary and Sexual Function Following Primary Focal Cryotherapy for Nonmetastatic prostate cancer.
Shah TT; Peters M; Miah S; Eldred-Evans D; Yap T; Hosking-Jervis F; Dudderidge T; Hindley RG; McCracken S; Greene D; Nigam R; Valerio M; Winkler M; Virdi J; Arya M; Ahmed HU; Minhas S
Eur Urol Focus; 2021 Mar; 7(2):301-308. PubMed ID: 31590961
[TBL] [Abstract] [Full Text] [Related]
13. [Supportive Care and Information Needs of cancer Survivors: A Comparison of Two Cohorts of Longterm cancers Survivors 5 and 10 Years after Primary cancer Diagnosis].
Lehmann-Laue A; Ernst J; Mehnert A; Taubenheim S; Lordick F; Götze H
Psychother Psychosom Med Psychol; 2020 Apr; 70(3-04):130-137. PubMed ID: 31466113
[TBL] [Abstract] [Full Text] [Related]
14. [The option of non-treatment as part of end-of-life care].
Hendriksen G; van Delden JJM
Ned Tijdschr Geneeskd; 2019 May; 163():. PubMed ID: 31187971
[TBL] [Abstract] [Full Text] [Related]
15. [A paradigm shift for prostate cancer diagnostics].
Bratt O
Lakartidningen; 2018 Oct; 115():. PubMed ID: 30351441
[TBL] [Abstract] [Full Text] [Related]
16. Itraconazole as a Noncastrating treatment for Biochemically Recurrent prostate cancer: A Phase 2 Study.
Lee M; Hong H; Kim W; Zhang L; Friedlander TW; Fong L; Lin AM; Small EJ; Wei XX; Rodvelt TJ; Miralda B; Stocksdale B; Ryan CJ; Aggarwal R
Clin Genitourin Cancer; 2019 Feb; 17(1):e92-e96. PubMed ID: 30327180
[TBL] [Abstract] [Full Text] [Related]
17. Psychological impact of different primary treatments for prostate cancer: A critical analysis.
Maggi M; Gentilucci A; Salciccia S; Gatto A; Gentile V; Colarieti A; Von Heland M; Busetto GM; Del Giudice F; Sciarra A
Andrologia; 2019 Feb; 51(1):e13157. PubMed ID: 30281167
[TBL] [Abstract] [Full Text] [Related]
18. A mitochondrial based oncology platform for targeting cancer stem cells (CSCs): MITO-ONC-RX.
Sotgia F; Ozsvari B; Fiorillo M; De Francesco EM; Bonuccelli G; Lisanti MP
Cell Cycle; 2018; 17(17):2091-2100. PubMed ID: 30257595
[TBL] [Abstract] [Full Text] [Related]
19. Phase 2 Study of Cyclophosphamide, Etoposide, and Estramustine in Patients With Castration-Resistant prostate cancer.
Laber DA; Chen MB; Jaglal M; Patel A; Visweshwar N
Clin Genitourin Cancer; 2018 Dec; 16(6):473-481. PubMed ID: 30072309
[TBL] [Abstract] [Full Text] [Related]
20. Psychological and functional effect of different primary treatments for prostate cancer: A comparative prospective analysis.
Sciarra A; Gentilucci A; Salciccia S; Von Heland M; Ricciuti GP; Marzio V; Pierella F; Musio D; Tombolini V; Frantellizzi V; Pasquini M; Maraone A; Guandalini A; Maggi M
Urol Oncol; 2018 Jul; 36(7):340.e7-340.e21. PubMed ID: 29706458
[TBL] [Abstract] [Full Text] [Related]
[Next]
